QuantRx Biomedical Corp.
| OTC Markets: QTXB
QuantRx Biomedical Corp. develops and commercializes PAD based products for the over-the-market and laboratory markets based on its patented technology platforms, and its genomic diagnostics, based on its patented PadKit technology for the worldwide healthcare industry. Its platforms include: inSync, Unique, PadKit, and OEM branded OTC and laboratory testing products based on the company's core intellectual property related to its PAD technology. The company's products are intended for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. QuantRx Biomedical was founded on December 5, 1986 and is headquartered in Tualatin, OR.